Home  >  Research  >  Labs  >  Cancer Program  >  LIVER DISEASE AND CARCINOGENESIS

RESEARCH OVERVIEW

Our research group focuses on the liver progenitor/stem cell (LPSC) which we identify in patients with alcoholic liver disease (ALD), hepatitis C (HCV), genetic hemochromatosis (GH) and non-alcoholic fatty liver disease (NAFLD). An objective of our research is to utilise their presence as a diagnostic to detect early stages of pathology and their abundance as an indicator of disease severity. Since ALD, GH, HCV and NAFLD increase the likelihood of developing hepatocellular carcinoma (HCC), the LPSCs may also be useful as a prognostic for patients who will develop liver cancer.

We are well-placed to undertake these studies as we have a monoclonal antibody that detects the LPSCs in liver biopsies. Our recent studies suggest that the protein this antibody binds to is present in the blood of patients who harbour LPSCs in their liver. This raises the possibility of developing a blood test that informs clinicians of the state of the patient’s liver.

The LPSC is present in diseased liver because it has an important role in repairing the damaged organ. It is a functional stem cell that can produce cholangiocytes that make up the bile ducts; or it can produce hepatocytes that are responsible for the major functions of the liver. To better study this important liver cell, we have established LPSC lines from both the mouse and human to understand what makes them grow and how they decide between generating cholangiocytes and hepatocytes.

This work has produced a valuable resource in the form of LPSC lines that are non-cancerous and others that are tumorigenic. This provides a platform for screening and testing for anti-liver cancer drugs that are selectively effective against liver cancer cells.

 

Emeritus Professor George Yeoh

Emeritus Professor George Yeoh

Liver Disease and Carcinogenesis

Read more

LATEST NEWS

People dressed in blue ride bicycles down a road under a start banner that says MACA Cancer 200 Ride for the Perkins

Perth Riders Raise $9 million for Cancer Research

Close to 1700 riders set off this morning from Riverside Drive cycling 100 kms to Mandurah, returning tomorrow to the Kingsman for the MACA Cancer 200 Ride for the Perkins. Before the Riders set off the Harry Perkins Institute of Medical Research CEO, Professor Peter Leedman AO announced that more…

Read More
Dr Elena Juan Pardo in qhite lab coat and Dr Abdul Ihdayid in dark suit.

Perkins researchers A/Prof Elena Juan Pardo and A/Prof Abdul Ihdayhid awarded $1M

Today on World Heart Day Harry Perkins Institute of Medical Research Associate Professor Elena Juan Pardo and Associate Professor Abdul Ihdayhid have been awarded $1 million by AUScelerate. The grant is to establish automated Good Laboratory Practice (GLP) ready manufacturing of bioengineered heart valves for clinical translation from the Targeted…

Read More

Perkins research finds new way to silence sarcoma gene

Perkins researchers have led a major collaborative study exploring a new way to switch off a key genetic driver of Ewing sarcoma, an aggressive cancer that mostly affects children and young people. Recently published in Molecular Therapy, the research brought together multiple teams from across the Perkins, The University of Western…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS